Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis

Overview of attention for article published in Frontiers in Medicine, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 41 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,125 followers.

la fibrosis pulmonar posterior a la COVID-19 es una consecuencia desafiante de la COVID-19, y nuestro caso sugiere que la pirfenidona puede ser una opción de tratamiento eficaz. #LongCovid #COVIDPERSISTENTE https://t.co/X2IqN3IDy6

24 Jun 2022

Reply Repost Favourite

RT @LongCovidPapers: Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis https://t.co/VtVpc2WjSI #LongCovid #pwLC

23 Jun 2022

Reply Repost Favourite

Case Report: Pirfenidone in the Treatment of Post-COVID-19 Pulmonary Fibrosis https://t.co/VtVpc2WjSI #LongCovid #pwLC

23 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.